Literature DB >> 25341136

Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.

Kyung Mi Jang1, Seong Hyun Kim, Ji Hye Min, Soon Jin Lee, Tae Wook Kang, Sanghyeok Lim, Dongil Choi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate whether the use of diffusion-weighted MRI (DWI) increases diagnostic accuracy in the differentiation of malignant from benign intraductal papillary mucinous neoplasms (IPMNs) of the pancreas over the accuracy of contrast-enhanced MRI with MRCP.
MATERIALS AND METHODS: A total of 61 patients with surgically resected IPMNs (19 malignant, 42 benign) who underwent gadoxetic acid-enhanced MRI, DWI, and MRCP were included. Two blinded observers evaluated two image sets, that is, conventional MRI with MRCP images versus combined conventional MRI with MRCP and DW images, and scored their confidence for malignancy of IPMNs. Qualitative analyses of the IPMNs were also conducted. Diagnostic performance (ROC curve analysis), accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were evaluated. The Fisher exact test was used to compare groups.
RESULTS: The diagnostic performance (area under the ROC curve [Az]) with respect to predicting malignancy of IPMNs improved significantly for both observers after additional review of DW images (p < 0.05). The diagnostic accuracy, sensitivity, specificity, PPV, and NPV of combined conventional and DW images were higher than those of conventional MR images alone. Diffusion restriction was more often present in malignant IPMNs (78.9%) than in benign IPMNs (16.7%) (p < 0.001) with excellent interobserver agreement (ĸ = 0.965).
CONCLUSION: Compared with conventional MRI alone, adding DWI to conventional MRI improves diagnostic accuracy with increased specificity for differentiating malignant from benign IPMNs of the pancreas.

Entities:  

Keywords:  MRI; diffusion-weighted imaging; intraductal papillary mucinous neoplasm; pancreas

Mesh:

Substances:

Year:  2014        PMID: 25341136     DOI: 10.2214/AJR.13.11980

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  Various diffusion magnetic resonance imaging techniques for pancreatic cancer.

Authors:  Meng-Yue Tang; Xiao-Ming Zhang; Tian-Wu Chen; Xiao-Hua Huang
Journal:  World J Radiol       Date:  2015-12-28

3.  Scan time reduction in diffusion-weighted imaging of the pancreas using a simultaneous multislice technique with different acceleration factors: How fast can we go?

Authors:  Jana Taron; Petros Martirosian; Thomas Kuestner; Nina F Schwenzer; Ahmed Othman; Jakob Weiß; Mike Notohamiprodjo; Konstantin Nikolaou; Christina Schraml
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

Review 4.  Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel.

Authors:  Elizabeth M Hecht; Gaurav Khatri; Desiree Morgan; Stella Kang; Priya R Bhosale; Isaac R Francis; Namita S Gandhi; David M Hough; Chenchan Huang; Lyndon Luk; Alec Megibow; Justin M Ream; Dushyant Sahani; Vahid Yaghmai; Atif Zaheer; Ravi Kaza
Journal:  Abdom Radiol (NY)       Date:  2020-11-13

Review 5.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 6.  Review of the diagnosis and management of intraductal papillary mucinous neoplasms.

Authors:  Stefano Crippa; Paolo G Arcidiacono; Francesco De Cobelli; Massimo Falconi
Journal:  United European Gastroenterol J       Date:  2019-12-09       Impact factor: 4.623

7.  Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.

Authors:  Jana Taron; Jonas Johannink; Michael Bitzer; Konstantin Nikolaou; Mike Notohamiprodjo; Rüdiger Hoffmann
Journal:  Cancer Imaging       Date:  2018-03-07       Impact factor: 3.909

8.  3D quantitative analysis of diffusion-weighted imaging for predicting the malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Takao Igarashi; Megumi Shiraishi; Ken Watanabe; Kazuyoshi Ohki; Shinsuke Takenaga; Hirokazu Ashida; Hiroya Ojiri
Journal:  Pol J Radiol       Date:  2021-05-19

9.  Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Fan Xu; Yingying Liang; Wei Guo; Zhiping Liang; Liqi Li; Yuchao Xiong; Guoxi Ye; Xuwen Zeng
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

Review 10.  Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers.

Authors:  Philippe Lévy; Vinciane Rebours
Journal:  Viszeralmedizin       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.